This company has shut down. Axonics Modulation Technologies is no longer operating — its last tracked round was a Post-IPO Equity in 2022.
Explore the Startup GraveyardAxonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Axonics Modulation Technologies has raised $111.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2022.
Axonics Modulation Technologies's investors include Legend Capital, Cormorant Asset Management, Andera Partners, Longitude Capital, Gilde Healthcare.
Axonics Modulation Technologies is headquartered in Irvine, United States.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Axonics Modulation Technologies is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axonics Modulation Technologies — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/axonics-modulation-technologies. Accessed July 19, 2026.
VCBacked. (2022). Axonics Modulation Technologies — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/axonics-modulation-technologies
{{cite web |title=Axonics Modulation Technologies — Funding & Investors |url=https://www.vcbacked.co/company/axonics-modulation-technologies |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated